Jeff Winters returns to explain how to use therapeutic apheresis to treat Thrombotic Thrombocytopenic Purpura (TTP).
Dr. Jeff Winters
Dr. Jeff Winters
About My Guest:
Dr. Jeff Winters is a graduate of the University of Kentucky College of Medicine. His postgraduate training included an Anatomic/Clinical Pathology residency at the University of Kentucky and a Transfusion Medicine/Blood Banking fellowship at the Mayo Clinic in Rochester, Minnesota. He is certified by the American Board of Pathology in Anatomic Pathology, Clinical Pathology, and Blood Banking/Transfusion Medicine.
Dr. Winters is a Professor of Laboratory Medicine and Pathology in the Mayo College of Medicine. He is the Program Director of the Mayo Clinic Transfusion Medicine/Blood Banking Fellowship Program, Vice-chair of the Division of Transfusion Medicine, and Medical Director of the Mayo Clinic Therapeutic Apheresis Treatment Unit.
Dr. Winters is actively involved in the American Society for Apheresis (ASFA) and previously served as the president of that organization. He is editor-in-chief of the Journal of Clinical Apheresis.
DISCLAIMER: The opinions expressed on this episode are those of my guest and I alone, and do not reflect those of the organizations with which either of us is affiliated. Neither Dr. Winters nor I have any relevant financial disclosures.
The images below are generously provided by Dr. Winters.
Relistening to this podcast. Lots of great information!
I’m wondering if anyone has looked at using recombinant DNA technology to produce ADAMTS13 for use in treating TTP. An infusion of ADAMTS13 would not help in terms of removing ultra-large vWF multimers or antibodies, but from the discussion my understanding is that (for patients who can tolerate the volume) infusion of plasma may sufficient to treat this condition.
Thanks again for a great discussion!
Hi Dr.Chaffin,
Is there a transcript available for this episode? Thank you very much!